russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLCrussjcardiol-1439Research ArticleКЛИНИКА И ФАРМАКОТЕРАПИЯGUIDELINES FOR THE PRACTITIONERСРАВНИТЕЛЬНАЯ ОЦЕНКА ВЛИЯНИЯ ПЕРИНДОПРИЛА, ТЕЛМИСАРТАНА И ИХ КОМБИНАЦИЙ НА КЛИНИКО-ФУНКЦИОНАЛЬНЫЕ ПАРАМЕТРЫ И ОКСИДАТИВНЫЙ СТРЕСС У БОЛЬНЫХ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ И САХАРНЫМ ДИАБЕТОМ 2 ТИПАEFFECTS OF PERINDOPRIL, TELMISARTAN, AND THEIR COMBINATIONS ON CLINICAL, FUNCTIONAL, AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUSБеленковЮ. Н.BelenkovYu. N.ПриваловаЕ. В.PrivalovaE. V.ЖелезныхЕ. А.ZheleznykhE. A.ДанилогорскаяЮ. А.DanilogorskayaYu. A.ЧекнёваИ. С.CheknevaI. S.АзизоваО. А.AzizovaO. A.АсейчевА. В.AseychevA. V.ШвачкоА. Г.ShvachkoA. G.Московская медицинская академия им. И.М. Сеченова РосздраваRussian FederationНИИ ФХМ Федерального медико-биологического агентства, МоскваRussian Federation201028042010025258Copyright © Беленков Ю.Н., Привалова Е.В., Железных Е.А., Данилогорская Ю.А., Чекнёва И.С., Азизова О.А., Асейчев А.В., Швачко А.Г., 20102010Беленков Ю.Н., Привалова Е.В., Железных Е.А., Данилогорская Ю.А., Чекнёва И.С., Азизова О.А., Асейчев А.В., Швачко А.Г.Belenkov Y.N., Privalova E.V., Zheleznykh E.A., Danilogorskaya Y.A., Chekneva I.S., Azizova O.A., Aseychev A.V., Shvachko A.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/1439
.
References2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation // Circulation 2009;119; e391-e479.2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation // Circulation 2009;119; e391-e479.American Diabetes Association – Standards of Medical Care in Diabetes 2009// Diabetes Care 2009; 32(1): S13-S61.American Diabetes Association – Standards of Medical Care in Diabetes 2009// Diabetes Care 2009; 32(1): S13-S61.Dzau V., Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement // Am Heart J. 1991; 121(4 Pt 1):1244-63.Dzau V., Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement // Am Heart J. 1991; 121(4 Pt 1):1244-63.Соловьева Э. Ю., Миронова О. П., Баранова О. А. и др. Свободнорадикальные процессы и антиоксидантная терапия при ишемии головного мозга // Журнал неврологии и психиатрии им. С.С. Корсакова, 2008; 6: 245-260.Соловьева Э. Ю., Миронова О. П., Баранова О. А. и др. Свободнорадикальные процессы и антиоксидантная терапия при ишемии головного мозга // Журнал неврологии и психиатрии им. С.С. Корсакова, 2008; 6: 245-260.Dzau V.J., Antman E.M., Black H.R. et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease)// Circulation 2006; 114(25):2850-70.Dzau V.J., Antman E.M., Black H.R. et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease)// Circulation 2006; 114(25):2850-70.Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure // J Clin Invest, 2005; 115: 500–508.Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure // J Clin Invest, 2005; 115: 500–508.Schraufstatter I.U., Hyslop P.A., Jackson J. et al. Oxidant injury of cell // Int J Tissue React, 1987; 9 (4): 317-324.Schraufstatter I.U., Hyslop P.A., Jackson J. et al. Oxidant injury of cell // Int J Tissue React, 1987; 9 (4): 317-324.Escargueil-Blanc I, Meilhac O, Pieraggi MT. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells trough a calcium-depended pathway. Prevention by aurintricarboxylic acid.// Tromb Vasc Biol, 1997; 17 (2): 331-339.Escargueil-Blanc I, Meilhac O, Pieraggi MT. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells trough a calcium-depended pathway. Prevention by aurintricarboxylic acid.// Tromb Vasc Biol, 1997; 17 (2): 331-339.Landmesser U., Spiekermann S., Dikalov S. et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase// Circulation, 2002; 106: 3073–3078.Landmesser U., Spiekermann S., Dikalov S. et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase// Circulation, 2002; 106: 3073–3078.Грызунов Ю.А., Добрецов Г.Е. Альбумин сыворотки крови в клинической медицине. М: ГЭОТАР, 1998.Грызунов Ю.А., Добрецов Г.Е. Альбумин сыворотки крови в клинической медицине. М: ГЭОТАР, 1998.Иванов С.Г., Ситникова М.Ю., Шляхто Е.В. Роль оксидативного стресса в развитии и прогрессировании хронической сердечной недостаточности: актуальность и возможность его коррекции// Кардиология СНГ, 2006; 4: 267-270.Иванов С.Г., Ситникова М.Ю., Шляхто Е.В. Роль оксидативного стресса в развитии и прогрессировании хронической сердечной недостаточности: актуальность и возможность его коррекции// Кардиология СНГ, 2006; 4: 267-270.Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress// J Biol Chem, 1997; 272: 20313–20316.Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress// J Biol Chem, 1997; 272: 20313–20316.Dalle-Donnea I., Rossib R., Giustarinib D. et al. Protein carbonyl groups as biomarkers of oxidative stress// Clinica Chimica Acta, 2003; 329: 23–38.Dalle-Donnea I., Rossib R., Giustarinib D. et al. Protein carbonyl groups as biomarkers of oxidative stress// Clinica Chimica Acta, 2003; 329: 23–38.Banfi C, Brioschi M, Barcella S, et al. Oxidized proteins in plasma of patients with heart failure: Role in endothelial damage// Eur. J. Heart Failure, 2008; 10(3): 244-251.Banfi C, Brioschi M, Barcella S, et al. Oxidized proteins in plasma of patients with heart failure: Role in endothelial damage// Eur. J. Heart Failure, 2008; 10(3): 244-251.McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans// Eur Heart J, 1993; 14: 1493–1498.McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans// Eur Heart J, 1993; 14: 1493–1498.Фёдорова Т.Н. Окислительный стресс и защита головного мозга от ишемического повреждения. Диссерт. …докт. медицинских наук, 2004.Фёдорова Т.Н. Окислительный стресс и защита головного мозга от ишемического повреждения. Диссерт. …докт. медицинских наук, 2004.Ball AM, Sole MJ. Oxidative stress and the pathogenesis of heart failure// Cardio Clin. 1998; 16 (7): 665-675.Ball AM, Sole MJ. Oxidative stress and the pathogenesis of heart failure// Cardio Clin. 1998; 16 (7): 665-675.Benson SC., Pershadsingh HA., Ho CI et al. Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist with Selective PPAR-γ Modulating Activity// Hypertension 2004; 43:993-1002.Benson SC., Pershadsingh HA., Ho CI et al. Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist with Selective PPAR-γ Modulating Activity// Hypertension 2004; 43:993-1002.Duan SZ., Usher MG., Mortensen NM. Peroxisome Proliferator-Activated Receptor-γ Mediated Effects in the Vasculature// Circulation Research 2008; 102:283-294.Duan SZ., Usher MG., Mortensen NM. Peroxisome Proliferator-Activated Receptor-γ Mediated Effects in the Vasculature// Circulation Research 2008; 102:283-294.Qingping Tian, Ryohei Miyazaki, Toshihiro Ichiki et al. Inhibition of Tumor Necrosis Factor-α-Induced IL-6 Expression by Telmisartan Through Cross-talk of Peroxisome Proliferator-Activated Receptor-γ with Nuclear Factor κβ and CCAAT/Enhancer Binding Protein β// Hypertension 2009; 53:798-804.Qingping Tian, Ryohei Miyazaki, Toshihiro Ichiki et al. Inhibition of Tumor Necrosis Factor-α-Induced IL-6 Expression by Telmisartan Through Cross-talk of Peroxisome Proliferator-Activated Receptor-γ with Nuclear Factor κβ and CCAAT/Enhancer Binding Protein β// Hypertension 2009; 53:798-804.
The authors declare that there are no conflicts of interest present.